Raymond M. Reilly at University of Toronto - Research Interests, Publications & Academic Profile

Raymond M. Reilly

University of Toronto

Canada

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Pakistani students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

20%

Immunology

20%

Radiopharmaceutical Chemistry

40%

Colloid Science

20%

Cancer Therapy

20%

Integrin Biology

20%

Nanomedicine

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177Lu

Article Link

Year:

2023

Cellular dosimetry of 197Hg, 197mHg and 111In: comparison of dose deposition and identification of the cell and nuclear membrane as important targets

Article Link

Year:

2023

90Y-Labeled Gold Nanoparticle Depot (NPD) Combined with Anti-PD-L1 Antibodies Strongly Inhibits the Growth of 4T1 Tumors in Immunocompetent Mice and Induces an Abscopal Effect on a Distant Non-Irradiated Tumor

Article Link

Year:

2022

Changing Surface Polyethylene Glycol Architecture Affects Elongated Nanoparticle Penetration into Multicellular Tumor Spheroids

Article Link

Year:

2022

Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer

Article Link

Year:

2022

Panitumumab-DOTA-111In: An Epidermal Growth Factor Receptor Targeted Theranostic for SPECT/CT Imaging and Meitner–Auger Electron Radioimmunotherapy of Triple-Negative Breast Cancer

Article Link

Year:

2022

MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases

Article Link

Year:

2021

Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [99mTc]-(I)-Tricarbonyl Complex

Article Link

Year:

2021

Site-Specific Conjugation of Metal-Chelating Polymers to Anti-Frizzled-2 Antibodies via Microbial Transglutaminase

Article Link

Year:

2021

Investigating the influence of block copolymer micelle length on cellular uptake and penetration in a multicellular tumor spheroid model

Article Link

Year:

2021

Collaborators1

Mitchell Winnik

Professor

University of Toronto

CANADA

How do Pakistani students reach out?

Meet Kite AI